Download now: https://lnkd.in/gSWJvfE8 Check out ‘The Integral Role of Global Indirect Treatment Comparison Programs in Europe’s JCA’ by Chris Cameron, Pamela V. and Monique Martin. Learn how a global ITC program is essential for #MarketAccess and #HTA submissions. #ITC #JCA
About us
EVERSANA® is a leading independent provider of global services to the life sciences industry. The company’s integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves more than 650 organizations, including innovative start-ups and established pharmaceutical companies, to advance life sciences solutions for a healthier world. To learn more about EVERSANA, visit eversana.com.
- Website
-
http://eversana.com
External link for EVERSANA
- Industry
- Pharmaceutical Manufacturing
- Company size
- 5,001-10,000 employees
- Headquarters
- Chicago, IL
- Type
- Privately Held
- Specialties
- Regulatory, Management & Specialty Consulting, Research & Insights, Global Pricing Strategies, Patient, Payer & Provider Marketing Services, Field Medical, Market Access & Sales , Global Channel Management & 3PL, Specialty Pharmacy & In-Home Nursing, HUB & Adherence Solutions, Affordability Programs, Medical Communications & Pharmacovigilance, Revenue Management, Digital Strategies & Therapy Transformation, Patient Analytics Services, Integrated Patient-Level Data, Commercial Analytics Platform, RWE & HEOR Global Services, Global Launch Expertise, and Payer Reimbursement Strategies
Locations
Employees at EVERSANA
Updates
-
Integration of strategic partnerships, cross-collaboration and business acumen are essential for optimizing #MedicalAffairs and #MedicalScienceLiaison (MSL) strategies and operations. EVERSANA leads the way in driving innovation and excellence through Medical Deployment solutions, helping manufacturers navigate industry challenges and deliver value to patients. In this new article by Susan Giacalone MSN, MSL-BC, BCMAS featured in the Medical Science Liaison Society Journal, discover how robust Medical Affairs operations and MSLs are essential to guide strategic engagement, navigate scientific complexities and optimize communication of key medical insights. Read now: https://ow.ly/7T7J50SEnWJ
-
Make a Difference as a Program Specialist! We are on the lookout for individuals who want to be Difference Makers in St. Louis. Join us in supporting patients and doctors and contribute to positive healthcare experiences. Apply now: https://ow.ly/lX2w50Rxwxa #DifferenceMakers #HealthcareJobs #NowHiring
-
-
If you missed the pharmaphorum #webinar on Tuesday, sponsored by EVERSANA - with Marty Culjat, SVP, global head of digital medicine and regulatory innovation, explaining the #PDURS framework, before he and Edward Cox, head & general manager of Digital Health & Medicines (DHM) at Pfizer, launched into a fireside chat with Jonah Comstock - then catch the conversation *on demand* now. #pharma #digital https://lnkd.in/e4e8Vdyt
-
-
Download now: https://ow.ly/oAkW50SkgH3 Traditional #oncology marketing-oriented journeys neglect the increasing complexities and advancing technologies and treatments in the market. EVERSANA INTOUCH’s pioneering Tumor Journey Model considers all decision points, tumor characteristics and interactions to enable more effective marketing interventions.
-
-
Learn More: https://lnkd.in/gqCHQkd9 Join Jim Lang, CEO of EVERSANA, as we co-host Frontiers Health 2024! Don’t miss out—use code FH24EVS20 for 20% off your tickets! #FH24 #healthinnovation #futurehealth #innovation #healthcare #lifesciences
-
-
Read the blog: https://ow.ly/CQpx50Sw2Ww Check out the latest AMCP Dossier Format Version 5.0. Learn about health disparities, real-world evidence, digital therapeutics, and more. Authors: Joshua Gauci, Irene Zahirovic (Zelner), PhD, Deepika Thakur #AMCP #HealthDisparities #RWE #DigitalTheraeutics
-
-
ICYMI: https://lnkd.in/gy5JXQzt Pharma is evolving, and Medical Affairs is leading the charge! Pierantonio Russo MD, FCPP, FAAP, STS, explores the transformative impact of Medical Affairs on drug commercialization. Read on for more on these emerging priorities and technologies. #PharmaTransformation #MedicalAffairs
-
-
Read More: https://lnkd.in/gqCHQkd9 We’re thrilled to announce that EVERSANA is the presenting sponsor of Frontiers Health 2024! Join us in #Berlin this October to connect with leading innovators and explore the future of healthcare. Get 20% off your tickets with code FH24EVS20! #FH24 #healthinnovation #futurehealth #innovation #healthcare #lifesciences
-
-
Read the article: https://ow.ly/Z4Q150SkgQ9 Personalized #immunotherapies are the next frontier in the fight against #cancer. The one-patient, one-medicine model presents new hurdles for manufacturers to overcome and requires unique strategies. Download the article to understand the market drivers, complexities and opportunities in the #oncology space.
-